SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys sharp post-earnings selloff despite a strong quarter and raised outlook is dominating discussion, with traders citing negative cash flow, heavy capacity spending, high valuation, and pressure on AI-linked stocks. Bulls see a buying opportunity based on growth and power demand, while bears question whether expansion can translate into sustainable cash generation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs continued slide toward lows is the main market focus, with bearish traders citing dilution, weak business prospects and Trump-related political risk. A smaller bullish contingent sees a possible rebound, while discussion also ties broader concern about the Iran conflict and oil prices to the political backdrop.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Leaked Phase 3 results for Modernas personalized melanoma vaccine with Keytrudashowing reduced recurrence risk but falling short of lofty expectationstriggered a sharp selloff and volatile rebound. Traders are split between viewing the results as clinically positive and calling the reaction a sell-the-news move, and questioning whether the benefit and commercial prospects justify the valuation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is drawing attention after conference presentations of promising early Phase 1 azer-cel results in progressive MS, alongside updated BRIUMVI data. Traders generally view the safety and early clinical signals positively, but note the small, uncontrolled study and mixed stock reaction; some see earnings and the later subcutaneous BRIUMVI readout as more important catalysts.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEPs sharp decline and repeated lows are fueling concern that its high distribution may be reduced, while unit distributions to Carl Icahn are seen by some traders as dilutive. Bulls counter that IEPs stake in CVR Energy may support its value and point to high short interest, but hopes for a rebound or squeeze remain speculative.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rallies on escalating Middle East tensions and fears of disruptions to Gulf oil shipments. Traders are split between those buying the breakout and those warning of an overextended, headline-driven move that could reverse if tensions ease.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo shares are drawing attention after MaxLinear outlined plans to target the 1.6T active electrical cable market, prompting concern among traders about competition with Credos established position. The reaction is divided between selling and buying the pullback, with some traders also pointing to broader AI-stock weakness and insider sales.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

FIGR is drawing attention amid a steep, persistent share-price decline, with bearish traders blaming insider or VC selling, short pressure, and concerns about management and dilution. Bulls counter that loan-marketplace growth, profitability, and its tokenized-finance platform support the business, leaving the community split between fears of further losses and a longer-term growth thesis.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is rallying with cybersecurity peers as reports of PHP vulnerabilities and broader AI-driven threat concerns renew interest in security stocks. Traders view the risks as a long-term demand tailwind, while some caution that high valuations and the sharp rebound may limit its staying power.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Shares are under pressure as traders focus on BDR Pharmaceuticals lawsuit challenging FDA protection for VOQUEZNAs exclusivity, raising concerns about earlier generic competition. Some investors view the dispute as a potentially lengthy overhang while sales continue to grow; others see it as a major risk to the companys outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY what percentage of triple negative breast cancer are of the MSS type? 
ChatGPT said: 
The vast majority of triple-negative breast cancer (TNBC) cases—over 95%—are microsatellite stable (MSS). 
 
Breakdown of MSI/MSS Status in TNBC: 
MSS (Microsatellite Stable): &gt;95% of TNBC cases fall into this category, meaning they have intact DNA mismatch repair (MMR) mechanisms and do not exhibit high microsatellite instability. 
MSI-H (Microsatellite Instability-High): &lt;5% of TNBC cases show MSI-H or deficient mismatch repair (dMMR), making them rare but potentially responsive to immunotherapy (e.g., pembrolizumab). 
Since TNBC is typically MSS, other biomarkers like PD-L1 expression, BRCA mutations, and tumor mutational burden (TMB) are more relevant for treatment decisions. 
 
Guess what leronlimab specializes in treating:  MSS type tumors; What is Keytruda FDA approved to treat?  PD-1 positive which are MSI type tumors.

J Valro

bradheb

MFSalvatore

Thomas H Butcher

The Goof

skilachi19

Nadia Karmo-Clark

Brian

Dale Harris

Karen Schydlowski

Bill Bohn

PNWtri

Syco Dyne

Maggie16

David Ca5

Mark Hayden

girma huresae

Timothy OConnor

LIVIMMUNE Bound

CJ Sigler

Steven feldman

Thor

Robert

Tuna T

Derek White

Saucier

christopher

StockTwits Web

CytoDyn Inc

 what percentage of triple negative breast cancer are of the MSS type? 
ChatGPT said: 
The vast majority of triple-negative breast cancer (TNBC) cases—over 95%—are microsatellite stable (MSS). 
 
Breakdown of MSI/MSS Status in TNBC: 
MSS (Microsatellite Stable): >95% of TNBC cases fall into this category, meaning they have intact DNA mismatch repair (MMR) mechanisms and do not exhibit high microsatellite instability. 
MSI-H (Microsatellite Instability-High): <5% of TNBC cases show MSI-H or deficient mismatch repair (dMMR), making them rare but potentially responsive to immunotherapy (e.g., pembrolizumab). 
Since TNBC is typically MSS, other biomarkers like PD-L1 expression, BRCA mutations, and tumor mutational burden (TMB) are more relevant for treatment decisions. 
 
Guess what leronlimab specializes in treating:  MSS type tumors; What is Keytruda FDA approved to treat?  PD-1 positive which are MSI type tumors.